CA1300005C - Sterilization of compositions of limited stability - Google Patents

Sterilization of compositions of limited stability

Info

Publication number
CA1300005C
CA1300005C CA000558096A CA558096A CA1300005C CA 1300005 C CA1300005 C CA 1300005C CA 000558096 A CA000558096 A CA 000558096A CA 558096 A CA558096 A CA 558096A CA 1300005 C CA1300005 C CA 1300005C
Authority
CA
Canada
Prior art keywords
buffer
formulation
sterilization
drug
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000558096A
Other languages
English (en)
French (fr)
Inventor
Milos Sovak
Stephen J. Foster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guerbet LLC
Original Assignee
Cook Imaging Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cook Imaging Corp filed Critical Cook Imaging Corp
Application granted granted Critical
Publication of CA1300005C publication Critical patent/CA1300005C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000558096A 1987-02-05 1988-02-04 Sterilization of compositions of limited stability Expired - Lifetime CA1300005C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/011,016 US4863714A (en) 1987-02-05 1987-02-05 Sterilization of compositions of limited stability
US011,016 1987-02-05

Publications (1)

Publication Number Publication Date
CA1300005C true CA1300005C (en) 1992-05-05

Family

ID=21748489

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000558096A Expired - Lifetime CA1300005C (en) 1987-02-05 1988-02-04 Sterilization of compositions of limited stability

Country Status (9)

Country Link
US (1) US4863714A (https=)
EP (1) EP0278674B1 (https=)
JP (1) JPH0667855B2 (https=)
AT (1) ATE79279T1 (https=)
AU (1) AU607461B2 (https=)
CA (1) CA1300005C (https=)
DE (1) DE3873553T2 (https=)
ES (1) ES2034184T3 (https=)
GR (1) GR3006111T3 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906130D0 (en) * 1989-03-17 1989-05-04 Nycomed As Compositions
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
DE4015832A1 (de) * 1990-05-17 1991-11-21 Thomae Gmbh Dr K Verfahren zur inaktivierung der biologischen aktivitaet von dna
AU701724B2 (en) * 1994-07-01 1999-02-04 Baxter International Inc. Biochemically balanced peritoneal dialysis solutions
US5605934A (en) * 1995-03-23 1997-02-25 Baxter International Inc. Method of manufacturing and storing solutions
US5972225A (en) * 1996-05-07 1999-10-26 Cook Imaging Corporation Process for remediating endotoxin-contaminated bulk non-ionic contrast media
US6309673B1 (en) 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
US7122210B2 (en) 2002-01-11 2006-10-17 Baxter International Inc. Bicarbonate-based solutions for dialysis therapies
US7445801B2 (en) * 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
US20060094700A1 (en) * 2004-11-02 2006-05-04 Allergan, Inc. Heat sterilization of a steroid in the presence of phosphate
US7935070B2 (en) * 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
JPWO2008146731A1 (ja) * 2007-05-25 2010-08-19 味の素株式会社 末梢静脈投与用輸液の製造方法
KR101915821B1 (ko) * 2010-03-23 2018-11-06 지이 헬스케어 에이에스 안정화된 ｘ―선 진단용 조성물의 제조
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224440A (en) * 1975-05-15 1980-09-23 Mallinckrodt, Inc. 1-(3,5-Disubstituted-2,4,6-triiodophenly)-3-(polyhydroxy-alkyl)urea compounds
AT371998B (de) * 1978-07-04 1983-08-25 Nyegaard & Co As Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels
GB2031405B (en) * 1978-07-04 1983-06-15 Nyegaard & Co As Process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer
FR2571367B1 (fr) * 1984-10-09 1987-02-13 Guerbet Sa Composes triaminobenzeniques iodes et/ou bromes, leur procede de preparation et leur application dans des produits de contraste
GB8717625D0 (en) * 1987-07-24 1987-09-03 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
JPH0667855B2 (ja) 1994-08-31
AU1133688A (en) 1988-08-11
EP0278674A2 (en) 1988-08-17
DE3873553D1 (de) 1992-09-17
ES2034184T3 (es) 1993-04-01
US4863714A (en) 1989-09-05
DE3873553T2 (de) 1993-02-18
GR3006111T3 (https=) 1993-06-21
EP0278674A3 (en) 1989-07-19
ATE79279T1 (de) 1992-08-15
AU607461B2 (en) 1991-03-07
JPH01221330A (ja) 1989-09-04
EP0278674B1 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
CA1300005C (en) Sterilization of compositions of limited stability
JP4861162B2 (ja) 注射用パラセタモール液状製剤
US6372243B2 (en) Low-oxygen fluorocarbon as an agent for ophthalmology
DK160741B (da) Kontrastmiddel til ultralyddiagnostik og fremgangsmaade til dets fremstilling
MCGUCKIN et al. An outbreak of Achromobacter xylosoxidans related to diagnostic tracer procedures
KR20020033782A (ko) 비경구 투여용의 약학적으로 안정된 옥살리백금 조제품 및그 조제방법
JP2915008B2 (ja) 眼内溶液の防腐方法及びそのための組成物
JPH0347161A (ja) ５―アミノサリチル酸の安定な液体形
US5177110A (en) Injectable parasiticidal composition
US11413241B2 (en) Method for preparing a composition with a low dissolved oxygen content, comprising acetaminophen, and optionally one or more NSAIDs, and a composition obtained thereof
Adkins et al. Sodium heparin neutralization and the anticoagulant effects of protamine sulfate
US2134246A (en) Stable solutions of ascorbic acid salts of histidine and process for the manufacture of same
US5650421A (en) Premixed famotidine formulation
JP3636372B2 (ja) メスナ注射液、その製造方法およびそれからなる、オキシアザホスホリン副作用をさけるための医薬
US3857677A (en) Method of sterile packaging
Clayton A simplified method for the culture of Blatella germanica under aseptic conditions
US4058213A (en) Low temperature vapor phase sterilization and storage of biologically active injectable materials
US2213977A (en) Pharmaceutical
US3347746A (en) Injectable solution of an amine salt of a radiopaque iodinated organic acid containing calcium ions
Lewisohn Twenty Years Experience With the Citrate Method of Blood Transfusion
US2739704A (en) Tertiary butyl alcohol as a tubing fluid
Carter et al. Multiple Autoclaving of Drugs Used in Spinal Anesthesia
Kessler Preservation of Bartonella muris in the frozen state
US3754040A (en) Sterilized glyceryl guaiacolate powder and process for manufacturing same
US20160144033A1 (en) Concentrated acetaminophen solution

Legal Events

Date Code Title Description
MKEX Expiry